Time to reconsider the role of ribavirin in Lassa fever
Ribavirin is the only available Lassa fever treatment. The rationale for using ribavirin is based on one clinical study conducted in the early 1980s. However, reanalysis of previous unpublished data reveals that ribavirin may actually be harmful in some Lassa fever patients. An urgent reevaluation o...
Main Authors: | Salam, AP, Cheng, V, Edwards, T, Olliaro, P, Sterne, J, Horby, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2021
|
Similar Items
-
Time to reconsider the role of ribavirin in Lassa fever.
by: Alex Paddy Salam, et al.
Published: (2021-07-01) -
Lack of evidence for ribavirin treatment of Lassa fever in systematic review of published and unpublished studies
by: Cheng, H-Y, et al.
Published: (2022) -
Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies
by: Hung-Yuan Cheng, et al.
Published: (2022-08-01) -
Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing.
by: Alex P Salam, et al.
Published: (2022-03-01) -
Ribavirin for Lassa Fever Postexposure Prophylaxis
by: Christiane M. Hadi, et al.
Published: (2010-12-01)